Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Analytical Sensitivity Analysis and Clinical Impact Modeling of Rapigen Rapid Diagnostic Tests for Malaria.

Golden A. et al, (2024), Am J Trop Med Hyg

Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.

Schilling WHK. et al, (2024), PLoS Med, 21

Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV).

Wongnak P. et al, (2024), Lancet Infect Dis, 24, 953 - 963

Lineage-informative microhaplotypes for recurrence classification and spatio-temporal surveillance of Plasmodium vivax malaria parasites.

Siegel SV. et al, (2024), Nat Commun, 15

Prevalence and genetic diversity of simian malaria in wild macaque populations across Thailand: Implications for human health.

Karnchaisri K. et al, (2024), Acta Trop, 254

Author Correction: Trio fluorophore-based phenotypic assay for the detection of artemisinin-induced growth-arrested Plasmodium falciparum in human erythrocytes.

Kobpornchai P. et al, (2024), Sci Rep, 14

Molecular markers of artemisinin resistance during falciparum malaria elimination in Eastern Myanmar.

Thu AM. et al, (2024), Malar J, 23

Primaquine in glucose-6-phosphate dehydrogenase deficiency: an adaptive pharmacometric assessment of ascending dose regimens in healthy volunteers.

Pukrittayakamee S. et al, (2024), Elife, 12

Primaquine in glucose-6-phosphate dehydrogenase deficiency: an adaptive pharmacometric assessment of ascending dose regimens in healthy volunteers

Pukrittayakamee S. et al, (2024), eLife, 12

Trio fluorophore-based phenotypic assay for the detection of artemisinin-induced growth-arrested Plasmodium falciparum in human erythrocytes.

Kobpornchai P. et al, (2024), Sci Rep, 14

Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial.

Luvira V. et al, (2024), BMC Infect Dis, 24

Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial.

Schilling WHK. et al, (2024), Lancet Infect Dis, 24, 36 - 45

A novel sensitive hexaplex high-resolution melt assay for identification of five human Plasmodium species plus internal control.

Srisutham S. et al, (2023), Acta Trop, 248

Corrigendum to: A novel sensitive hexaplex high-resolution melt assay for identification of five human Plasmodium species plus internal control (Acta Tropica, volume 248, article number 107020).

Srisutham S. et al, (2023), Acta Trop

Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV).

Jittamala P. et al, (2023), J Infect Dis, 228, 1318 - 1325

Application of loop-mediated isothermal amplification combined with lateral flow assay visualization of Plasmodium falciparum kelch 13 C580Y mutation for artemisinin resistance detection in clinical samples.

Sanmoung W. et al, (2023), Acta Trop, 246

Pharmacokinetics of single low dose primaquine in Ugandan and Congolese children with falciparum malaria.

Mukaka M. et al, (2023), EBioMedicine, 96

Limited Polymorphism in the Dihydrofolate Reductase (dhfr) and dihydropteroate synthetase genes (dhps) of Plasmodium knowlesi isolate from Thailand.

Sangsri R. et al, (2023), Acta Trop

Evolution of genetic markers for drug resistance after the introduction of dihydroartemisinin-piperaquine as first-line anti-malarial treatment for uncomplicated falciparum malaria in Indonesia.

Rahmasari FV. et al, (2023), Malar J, 22

In vitro activity of rhinacanthin analogues against drug resistant Plasmodium falciparum isolates from Northeast Thailand.

Chaorattanakawee S. et al, (2023), Malar J, 22

Load More

Include forthcoming?